Variable | OS | DFS | N |
---|---|---|---|
Survival is in months (median (SEM)). | |||
ER, oestrogen receptor; IHPI, immunohistochemical prognostic index; LAC, locally advanced carcinoma; PR, progesterone receptor. | |||
c-erbB-2 | |||
Negative | 142 (17) | 94 (17) | 41 |
Positive | 58 (8) | 31 (5) | 67 |
p Value | <0.05 | NS | |
p53 | |||
Negative | 100 (28) | 71 (35) | 75 |
Positive | 57 (6) | 34 (7) | 33 |
p Value | <0.05 | NS | |
ER | |||
Positive | >212 | >212 | 36 |
Negative | 57 (9) | 31 (5) | 72 |
p Value | <0.001 | <0.01 | |
PR | |||
Positive | >212 | >212 | 40 |
Negative | 55 (4) | 29 (5) | 68 |
p Value | <0.0001 | <0.0001 | |
IHPI | |||
Good | >212 | >212 | 32 |
Moderate | 96 (35) | 34 (10) | 23 |
Poor | 51 (8) | 29 (6) | 53 |
p Value | <0.0001 | <0.001 |